ANN M. HANLY

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANN M. HANLY:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vir Biotechnology, Inc. EVP & Chief Technology Officer Common Stock 117,901 $1,114,565 $9.45 24 Feb 2025 Direct
Vir Biotechnology, Inc. EVP & Chief Technology Officer Stock Option (Right to Buy) 65,000 $99,450 $1.53 22 Feb 2024 Direct

Insider Reports Filed by ANN M. HANLY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VIR Vir Biotechnology, Inc. 24 Feb 2025 1 -$133,936 4 EVP & Chief Technology Officer 25 Feb 2025, 15:43
VIR Vir Biotechnology, Inc. 01 Apr 2024 1 -$27,251 4 EVP & Chief Technology Officer 02 Apr 2024, 20:58
VIR Vir Biotechnology, Inc. 22 Feb 2024 3 -$123,521 4 EVP & Chief Technology Officer 26 Feb 2024, 19:34
VIR Vir Biotechnology, Inc. 30 Mar 2023 1 -$59,817 4 Chief Technology Officer 31 Mar 2023, 14:40
VIR Vir Biotechnology, Inc. 22 Feb 2023 3 -$59,790 4 Chief Technology Officer 24 Feb 2023, 19:35
VIR Vir Biotechnology, Inc. 30 Mar 2022 1 -$68,925 4 Chief Technology Officer 31 Mar 2022, 14:46
VIR Vir Biotechnology, Inc. 22 Feb 2022 2 $0 4 Chief Technology Officer 24 Feb 2022, 20:33
VIR Vir Biotechnology, Inc. 29 Nov 2021 1 +$500 4 Chief Technology Officer 01 Dec 2021, 19:20